Test helps in fight against lung infections and for treating other life-threatening infectionsJuly 29, 2009Edmonton, Alberta - A new test developed by Edmonton-based Innovotech™ Inc. will now allow doctors to more accurately identify the right antibiotics required to treat serious, chronic infections that are biofilm based. With more than 80 per cent of infections in the developed world caused by biofilms, the potential for this new breakthrough test, called bioFILM PA™, is of immense significance to the medical community. Chronic infections place a major cost burden on the health system. Patients spend more time in hospitals, antibiotic costs and treatment costs increase as more aggressive treatment options are explored, and the potential always exists for these infections to cause death. Until bioFILM PA™, treatment of chronic infections required trying different antibiotics until one or several together eliminated or controlled the bacteria in the biofilm. With each failed treatment, not only would a patient's health be jeopardized, and health care costs increased, but the bacteria would be more likely to develop resistance to one or more antibiotics. Biofilm infections can be 1000 times more resistant to antibiotics than conventional infections. Now, for the first time ever, the breakthrough test developed by Innovotech™ Inc. has shown very positive results in selecting proper antibiotic treatment for serious lung infections in patients with Cystic Fibrosis (CF), a population recognized as having among the most life threatening lung infections. Clinical research of bioFILM PA™ shows how the test can provide guidance to doctors on the right antibiotics to treat infections in a biofilm state. In developing bioFILM PA™, Innovotech™ recognized that current testing was for free-floating or single bacteria, whereas CF lung infections and other chronic infections were caused by bacteria in a biofilm state which are much more difficult to kill than free-floating bacteria. While the clinical research focused on patients with CF, the bioFILM PA™ test shows potential for use on other serious bacterial biofilm infections caused by this bacterium, such as chronic pneumonia, burns and wounds. Furthermore, Innovotech™ has development plans in place for companion products to bioFILM PA™ that will address biofilm infections caused by other bacteria such as infections of catheters, artificial joints, mechanical heart valves and other devices. Innovotech™ Inc. developed bioFILM PA™ and the University of Alberta Hospital laboratory, under the direction of Dr. Robert Rennie, Site Chief, Laboratory Medicine and Dr. Neil Brown, Director, Adult Cystic Fibrosis Clinic conducted the clinical research from 2007 to 2009. The clinical research involved 14 patients with cystic fibrosis at the University of Alberta hospital CF clinic. The patients ranged from 9 to 51 years of age. One patient was receiving intravenous antibiotics for a lung infection but continued to decline in health and lung function. The same antibiotics had been used for an earlier infection and had been successful. The patient was hospitalized, the antibiotics were changed, but the patient continued to decline. Using the bioFILM PA™ kit as guidance, an additional antibiotic not normally used in CF lung infections was added. The patient responded to the treatment, was discharged and is still symptom free after more than one year. In another case, a patient was on a lung transplant waiting list, and was receiving oral and inhaled antibiotics, but showed a continuous decline in health and lung function. The doctors admitted the patient to hospital in an attempt to stabilize the patient prior to transplantation. A bioFILM PA™ test was ordered and consequently a new combination of antibiotics was administered. The lung transplant was conducted successfully and the patient has been symptom free for more than two years. Innovotech Inc. |
|||||||||||||||||||||
| Related Biofilms Current Events and Biofilms News Articles Bacteria 'launch a shield' to resist attack Researchers from the University of Copenhagen and the Technical University of Denmark along with other collaborators in Denmark and the US found that the bacterium Pseudomonas aeruginosa can 'switch on' production of molecules that kill white blood cells - preventing the bacteria being eliminated by the body's immune system. UTSA biology researchers demystify elusive war zone bacterium Tao Weitao, a researcher in the College of Sciences' Department of Biology at the University of Texas at San Antonio is making great strides in a project that was funded one year ago by the San Antonio Area Foundation. New lab-on-a-chip measures mechanics of bacteria colonies Researchers at the University of Michigan have devised a microscale tool to help them understand the mechanical behavior of biofilms, slimy colonies of bacteria involved in most human infectious diseases. Plant Microbe Shares Features with Drug-Resistant Pathogen An international team of scientists has discovered extensive similarities between a strain of bacteria commonly associated with plants and one increasingly linked to opportunistic infections in hospital patients. Cool plasma packs heat against biofilms Though it looks like a tiny purple blowtorch, a pencil-sized plume of plasma on the tip of a small probe remains at room temperature as it swiftly dismantles tough bacterial colonies deep inside a human tooth. Texas A&M researchers examine 'invading' bacteria in DNA Researchers at Texas A&M University's Artie McFerrin Department of Chemical Engineering have discovered how certain types of bacteria integrate the DNA that they have captured from invading enemies into their own genetic makeup to increase their chances of survival. hus the bile does not overflow A consequence of the different cancers of the hepatobiliary system is blocked bile ducts. However, artificial catheters known as "stents" can remediate this problem. Corrosion-inhibiting coatings containing 'good' bacteria A new, environmentally friendly coating that protects metals against corrosion in seawater has been developed by a team of researchers from Sheffield Hallam University. Genes that make bacteria make up their minds Bacteria are single cell organisms with no nervous system or brain. So how do individual bacterial cells living as part of a complex community called a biofilm "decide" between different physiological processes (such as movement or producing the "glue" that forms the biofilm)? Queen's scientists find new way to battle MRSA Experts from Queen's University Belfast have developed new agents to fight MRSA and other hospital-acquired infections that are resistant to antibiotics. The fluids are a class of ionic liquids that not only kill colonies of these dangerous microbes, they also prevent their growth. More Biofilms Current Events and Biofilms News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||